$ADHD to Release Fiscal 2016 Financial Results


    Alcobra Ltd. to Release Fiscal 2016 Financial Results and Participate at the BIO CEO & Investor Conference in New York

    Alcobra Ltd. (ADHD), an emerging pharmaceutical company focused on the development of new medications to treat CNS and cognitive disorders, today announced that it will report its financial results for the year ended December 31, 2016 on Wednesday, February 15, at 8:30 am Eastern Time. The company also announced a corporate presentation at the BIO CEO & Investor Conference, being held on February 13-14, 2017 at the Waldorf Astoria in New York City.

    FY2016 Financial Results Conference Call & Webcast
    Wednesday, February 15th @ 8:30am Eastern Time
    Domestic: 855-469-0611
    International: 484-756-4341
    Conference ID: 63950344
    Webcast: http://edge.media-server.com/m/p/662vg37q

    Replays available through March 2, 2017
    Domestic: 855-859-2056
    International: 404-537-3406
    Passcode: 63950344

    BIO CEO & Investor Conference
    Tuesday, February 14th at 8:30am Eastern Time
    Location: Waldorf Astoria, New York
    Webcast: http://www.veracast.com/webcasts/bio/ceoinvestor2017/54203411117.cfm
    About Alcobra
    Alcobra Ltd. is an emerging pharmaceutical company primarily focused on the development and commercialization of medications to treat CNS and cognitive disorders. For more information, please visit the Company’s website, www.alcobra-pharma.com, the content of which is not incorporated herein by reference.


    Please enter your comment!
    Please enter your name here